Table 1.
2017 ACC/AHA Guideline | JNC7 Guideline | |||
---|---|---|---|---|
Hypertension | Recommended Anti-hypertensive Medication | Hypertension | Recommended Anti-hypertensive Medication | |
Overall | 45.6 (43.6–47.6) | 36.2 (34.2–38.2) | 31.9 (30.1–33.7) | 34.3 (32.5–36.2) |
Age group (years) | ||||
20–44 | 24.0 (21.8–26.2) | 12.5 (11.2–13.9) | 10.5 (9.4–11.7) | 12.2 (10.9–13.6) |
45–54 | 47.1 (44.4–49.8) | 33.4 (30.8–36.1) | 29.5 (27.0–32.2) | 32.7 (30.1–35.4) |
55–64 | 66.6 (63.6–69.5) | 58.2 (54.9–61.4) | 52.4 (49.1–55.7) | 55.0 (62.0–58.0) |
65–74 | 75.6 (73.4–77.6) | 74.1 (71.4–76.6) | 63.6 (60.2–66.9) | 66.9 (63.7–69.9) |
≧75 | 82.3 (79.2–85.0) | 82.3 (79.2–85.0) | 75.1 (71.9–78.1) | 78.5 (74.7–81.8) |
Men | 48.6 (45.9–51.3) | 37.3 (34.9–39.8) | 32.0 (29.8–34.3) | 34.8 (32.4–37.3) |
Women | 42.9 (40.7–45.1) | 35.1 (33.1–37.3) | 31.8 (29.8–33.8) | 33.8 (31.8–35.9) |
History of cardiovascular disease | 79.3 (75.6–82.6) | 79.3 (75.6–82.6) | 72.1 68.8–75.3) | 75.7 (72.7–78.4) |
Values are % of American adults (95% confidence interval). ACC/AHA, American College of Cardiology/American Heart Association; JNC7, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure.